Switch View
© PR Newswire
24.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 10, 2025 to Discuss Your Rights - LNTH
News Preview
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Baxter International, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - BAX
News Preview
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ("Baxter International, Inc." or the "Company") (NYSE: BAX) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Shareholders that lost money on Semler Scientific, Inc.(SMLR) should contact Levi & Korsinsky about pending Class Action - SMLR
News Preview
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
24.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Shareholders of LifeMD, Inc. Should Contact Levi & Korsinsky Before October 27, 2025 to Discuss Your Rights - LFMD
News Preview
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
24.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit - ATYR
News Preview
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Class Action Filed Against Savara Inc. (SVRA) Seeking Recovery for Investors - Contact Levi & Korsinsky
News Preview
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Class Action Filed Against Cytokinetics, Incorporated (CYTK) - November 17, 2025 Deadline to Join - Contact Levi & Korsinsky
News Preview
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: US98887Q1040
Zai Lab Limited
ZLAB
LISTED
NASDAQ
Zai Lab Announces Updated Phase 1 Data for Zocilurtatug Pelitecan (formerly ZL-1310), Demonstrating Potential as a First-in-Class/Best-in-Class DLL3-Targeted ADC for Small Cell Lung Cancer, and Initiation of Global Phase 3 Registrational Study
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced updated data from the global Phase 1 clinical trial of zocilurtatug pelitecan (zoci), formerly known as ZL-1310, (NCT06179069) demonstrating robust and durable responses in heavily pre-treated patients with extensive-stage small cell lung cancer (ES-SCLC). This data will be presented as an...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: CA46604F1099
Izotropic Corporation
IZO
LISTED
CSE
Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System
News Preview
NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and...
Themefolio
Profiler
Peergroup
© Newsfile
24.10.2025
ISIN: CA25244H1055
DiagnosTear Technologies Inc.
DTR
LISTED
CSE
DiagnosTear Technologies Inc. Announces Upsizing of Private Placement of Units
News Preview
Vancouver, British Columbia--(Newsfile Corp. - October 24, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company") is pleased to announce, further to its press release from June 3, 2025, its previously announced non-brokered private placement of units ("Units") at a price of $0.50 per Unit has been increased to...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US00773U2078
Adverum Biotechnologies Inc
ADVM
LISTED
NASDAQ
Lilly to Acquire Adverum Biotechnologies
News Preview
Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose
Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gen...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Icotrokinra long-term results affirm promise of targeted oral peptide with high rates of durable skin clearance and favorable safety profile in difficult-to-treat scalp and genital psoriasis
News Preview
In areas of high impact, 72% of patients with scalp psoriasis and 85% with genital psoriasis treated with icotrokinra achieved site-specific clear or almost clear skin at Week 52 in Phase 3 ICONIC-TOTAL study
67% of patients treated with icotrokinra achieved ove...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
24.10.2025
ISIN: JP3546800008
Terumo Corporation
45430
LISTED
XJPX
Terumo Interventional Systems Announces Its New OPUSWAVE® Dual Sensor Imaging System and DualView® Imaging Catheter Receive FDA 510(k) Clearance
News Preview
OPUSWAVE Imaging System combines OFDI and IVUS into a single catheter, providing significant potential to reduce procedural time and costs in treating coronary artery disease
DualView imaging catheter
offers a 150...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: NL0011606264
Merus N.V.
MRUS
LISTED
NASDAQ
Merus’ Interim Data on Petosemtamab in Metastatic Colorectal Cancer Demonstrates Monotherapy Activity and Robust Response Rate in Combination with FOLFOX/FOLFIRI with Well Tolerated Safety
News Preview
– 100% response rate in 1L left-sided mCRC (n=8, confirmed and unconfirmed)...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction
News Preview
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which owns 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today issued the following statement regarding the agreement between STAAR and Alcon Inc. (“Alcon”) (NYSE: ALC) to postpone a shareholder vote on the proposed sale...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: US26622P1075
Doximity Inc
DOCS
LISTED
NYSE
Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Doximity Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders.
If you currently own Doximity stock and acquired shares on or before June 24, 2021, you may be able to seek corporate governance reforms, the return of funds back to...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
Sobi showcases new data across rare inflammatory conditions at ACR 2025
News Preview
STOCKHOLM, Oct. 24, 2025 /PRNewswire/ -- Sobi® (STO: SOBI), a global biopharmaceutical company dedicated to delivering innovative treatments for patients with rare disease, will be presenting new data across its immunology portfolio at the annual American College of Rheumatology (ACR) Convergence 2025 meeting in...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: US40412C1018
HCA Healthcare Inc
HCA
LISTED
NYSE
HCA Healthcare Reports Third Quarter 2025 Results
News Preview
HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2025.
Key third quarter metrics (all percentage changes compare 3Q 2025 to 3Q 2024 unless otherwise noted):
Revenues increased 9.6 percent to $19.161 billion
Net income attributable to HCA Healthcare, Inc. increased 29...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: US74587B1017
Pulse Biosciences Inc
PLSE
LISTED
NASDAQ
Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the enrollment of the first patient in its NANOCLAMP AF Study for the treatment of atrial fibrillation (AF). The successful first procedure was complete...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: CA1380357048
Canopy Growth Corp
CGC
LISTED
NASDAQ
Canopy Growth to Report Second Quarter Fiscal 2026 Financial Results on November 7, 2025
News Preview
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2026 ended September 30, 2025 before financial markets open on November 7, 2025.
Following the release of its second quarter fiscal year 2026 financial results, Canopy Growth will host an audio...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: CH0329023102
AC Immune SA
ACIU
LISTED
NASDAQ
First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine
News Preview
First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
News Preview
This trial is the first and largest study specifically designed to evaluate children and adolescents with severe alopecia areata, a population often underrepresented in clinical trials
New data show 71% of adolescents with severe disease treated with baricitini...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis
News Preview
New long-term extension data show approximately 80% of patients achieved or maintained meaningful skin improvement (EASI 75) with EBGLYSS with half the doses compared to approved monthly maintenance dosing
Lilly submitted these data to the FDA for a potential l...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US31573L1052
FibroBiologics Inc.
FBLG
LISTED
NASDAQ
FibroBiologics to Present at Bio-Europe 2025
News Preview
HOUSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US03836J1025
Aprea Therapeutics Inc
APRE
LISTED
NASDAQ
Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051
News Preview
DOYLESTOWN, Pa., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while minimizing damage to healthy cells, today provided an update on the ongoing Phase 1 ACESOT-1051...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: US22407B1089
Coya Therapeutics, Inc.
COYA
LISTED
NASDAQ
Coya Therapeutics Announces Pricing of $20 Million Upsized Public Offering of Common Stock
News Preview
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, today announced that it has priced an underwritten public offering of 3,636,364 shares of its common stock at a public...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: US90184D1000
Twist Bioscience Corp
TWST
LISTED
NASDAQ
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders.
If you currently own Twist stock and acquired shares on or before December 20, 2018, you may be able to seek corporate governance reforms, the retur...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US9553061055
West Pharmaceutical Services Inc
WST
LISTED
NYSE
West to Participate in Upcoming Investor Conferences
News Preview
EXTON, Pa., Oct. 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences: ...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US03969K1088
Arcutis Biotherapeutics Inc
ARQT
LISTED
NASDAQ
Arcutis to Present New Quality of Life and Long-Term Data with ZORYVE® (roflumilast) Cream 0.15% and 0.05% for the Treatment of Atopic Dermatitis at the Fall Clinical Dermatology Conference
News Preview
WESTLAKE VILLAGE, Calif. and LAS VEGAS, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that new data demonstrating ZORYVE® (roflumilast) cream 0.15% and 0.05% improved quality of life, s...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US45826H1095
Integer Holdings Corp
ITGR
LISTED
NYSE
Payman Khales Assumes Role as Integer President and CEO
News Preview
~ Planned Leadership Transition Completed ~...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US00773J2024
Spyre Therapeutics Inc
SYRE
LISTED
NASDAQ
Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025
News Preview
WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases, today announced scientific presentations at the ACR Convergenc...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US09075V1026
Biontech SE
BNTX
LISTED
NASDAQ
Pfizer and BioNTech Receive Health Sciences Authority Approval for SARS-CoV-2 Sublineage LP.8.1-Adapted Monovalent COVID-19 Vaccine in Singapore
News Preview
The updated COVID-19 vaccine is
expected to be available in Singapore at selected polyclinics and private general practitioner (GP) clinics in October 2025 for individuals 6 months of age and older.
SI...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio
News Preview
CAMBRIDGE, Mass. and CHICAGO, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Vanqua Bio today announced a license agreement granting Biogen exclusive worldwide rights to Vanqua’s preclinical, oral C5aR1 antagonist. This agreement strengthens Biogen’s immunology strategy by advancing a proven immune mechanism with the potential...
Themefolio
Profiler
Peergroup
© EQS Newswire
24.10.2025
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Umplatzierung der Aktien von Bencis
News Preview
Pressemitteilung
Medios AG: Umplatzierung der Aktien von Bencis
Berlin, 24. Oktober 2025 – Die Medios-Gruppe („Medios“ oder „das Unternehmen“), ein führender Anbieter von Specialty Pharma in Europa, wurde darüber informiert, dass Bencis Capital Partners B.V. („Bencis“) ihren gesamten Aktienbesitz an der Medios AG umplatziert hat. Die Aktien, die ......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.10.2025
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Reallocation of Bencis shares
News Preview
Press release
Medios AG: Block placement of Bencis shares
Berlin, October 24, 2025 – The Medios-Group (“Medios“ or “the Company”), a leading provider of Specialty Pharma in Europe, was informed that Bencis Capital Partners B.V. ("Bencis") has reallocated its entire shareholding in Medios AG. The shares, which represent a total of approx. 6.7% of ......
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US50127T1097
Kura Oncology Inc
KURA
LISTED
NASDAQ
Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin
News Preview
- Milestone triggered by dosing of first patient in frontline AML Phase 3 clinical program- ...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US7867001049
Sagimet Biosciences Inc
SGMT
LISTED
NASDAQ
Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference
News Preview
Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical trial in acne in China conducted by license partner Ascletis...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US61225M1027
Monte Rosa Therapeutics Inc
GLUE
LISTED
NASDAQ
Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2025 on the Potential of MRT-6160, a VAV1-directed Molecular Glue Degrader, to Treat Immune-mediated Diseases
News Preview
Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2025 on the Potential of MRT-6160...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: CA39342L1085
Green Thumb Industries Inc
GTII
LISTED
CSE
Green Thumb Industries to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
CHICAGO and VANCOUVER, British Columbia, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced it will release third quarter 2025 financial results after the market closes on Wednesday, Nove...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US00182C1036
ANI Pharmaceuticals Inc
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET
News Preview
PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its third quarter 2025 financial results on Friday, November 7, 2025, prior to the market open....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
24.10.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC PINK:MDCE) Approved as Official Apple Developer
News Preview
Company advances digital technology initiatives with approval to publish applications on Apple's App Store MESA, ARIZONA / ACCESS Newswire / October 24, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a technology-driven company specializing in innovative digital health and AI applications, today announced that it has been formally approved...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
24.10.2025
ISIN: US45840Y2037
Interactive Strength, Inc.
TRNR
LISTED
NASDAQ
Interactive Strength Inc. (NASDAQ: TRNR) to Release Third-Quarter Results on Friday, November 14, 2025
News Preview
AUSTIN, TEXAS / ACCESS Newswire / October 24, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR, FORME and Wattbike brands and pending acquirer of Sportstech, today announced it will release financial results for its third quarter ended Septe...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: KYG4212K1040
Gushengtang Holdings Limited
2273
LISTED
HKSE
Gushengtang TCM and 1doc Form Strategic Partnership to Establish Singapore's Integrated TCM Service Model
News Preview
SINGAPORE, Oct. 24, 2025 /PRNewswire/ -- Gushengtang TCM officially launched its "Master TCM AI" system at GovWare 2025 on October 22. The launch coincides with a strategic partnership with 1doc and a signed agreement with August Global Partners (AGP) for strategic investment, supporting the shift toward evidence...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US14843C1053
Castle Biosciences Inc
CSTL
LISTED
NASDAQ
New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference
News Preview
Castle is presenting data on DecisionDx®-Melanoma and its pipeline atopic dermatitis (AD) test at the 25th Annual Fall Clinical Dermatology Conference....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
24.10.2025
ISIN: US60458C1045
Mira Pharmaceuticals Inc
MIRA
LISTED
NASDAQ
MIRA Pharmaceuticals Initiates Multiple Ascending Dose (MAD) Phase 1 Study of Oral Ketamir-2 and Selects Chemotherapy-Induced Neuropathic Pain as Lead Phase 2a Indication
News Preview
Advancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track consideration MIAMI, FLORIDA / ACCESS Newswire / October 24, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company devel...
Themefolio
Profiler
Peergroup
© EQS Newswire
24.10.2025
ISIN: CH0038389992
BB Biotech AG
BION
LISTED
SIX
BB Biotech AG publishes its interim report
News Preview
Ad hoc announcement pursuant to Art. 53 LR
October 24, 2025
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at September 30, 2025, which covers the results of its business activities for the first nine months of 2025.
Based on the consolidated accounts of BB Biotech AG, net prof......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.10.2025
ISIN: CH0038389992
BB Biotech AG
BION
LISTED
SIX
BB Biotech AG veröffentlicht Zwischenbericht
News Preview
Ad hoc-Mitteilung gemäss Art. 53 KR
24. Oktober 2025BB Biotech AG veröffentlicht Zwischenbericht
Die BB Biotech AG (ISIN CH0038389992) hat heute den Zwischenbericht per 30. September 2025 veröffentlicht, welcher über die Ergebnisentwicklung für die ersten neun Monate 2025 informiert.
Basierend auf den konsolidierten Zahlen weist die BB Biotech A......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.10.2025
ISIN: CH0038389992
BB Biotech AG
BION
LISTED
SIX
Portfolio übertrifft Benchmark – erste Anzeichen einer Branchen-Erholung
News Preview
Medienmitteilung vom 24. Oktober 2025
BB Biotech Q3 2025: Portfolio übertrifft Benchmark – erste Anzeichen einer Branchen-Erholung
Aktienkurs: +20.0% in CHF / +20.1% in EUR / +19.5% in USD – deutlich besser als der Nasdaq Biotech Index (NBI), der um +15.6% in USD zulegte
NAV: +24.0% in CHF / +24.0% in EUR / +23.5% in USD – eine Outperformance v......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.10.2025
ISIN: CH0038389992
BB Biotech AG
BION
LISTED
SIX
Portfolio outperformance amid early signs of sector recovery
News Preview
Media release as at October 24, 2025
BB Biotech Q3 2025: Portfolio outperformance amid early signs of sector recovery
Share price: +20.0% in CHF / +20.1% in EUR / +19.5% in USD – notably outperforming the Nasdaq Biotech Index (NBI), which gained +15.6% in USD
NAV: +24.0% in CHF / +24.0% in EUR / +23.5% in USD – surpassing the benchmark NBI by 7......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.10.2025
ISIN: CH1251125998
Relief Therapeutics Holding SA
RLF
LISTED
SIX
Relief Therapeutics Convenes Extraordinary General Meeting
News Preview
Relief Therapeutics Convenes Extraordinary General Meeting
GENEVA (Oct. 24, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief Therapeutics or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced it has convened an e......
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: KYG0330A1013
Alphamab Oncology
9966
LISTED
HKSE
Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/αvβ6 Bispecfic ADC JSKN022
News Preview
SUZHOU, China, Oct. 24, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed at Sun Yat-sen University Cancer Center in the phase I clinical study (Study ID: JSKN022-101) of JSKN022, an independently developed innovative bispecific antibody-drug...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development’s portfolio company SVF Vaccines presents positive data from a preclinical study of SVF-001 in chronic hepatitis B and D
News Preview
STOCKHOLM, Sweden, October 24, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has presented positive results from a preclinical study of its immunotherapy SVF-001 targeting chronic hepatitis B and D at the Molecular Biology of HBV meeting in Berlin and the DeltaCure meeting in Hannover....
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
49,164 Orion Corporation A shares converted into B shares
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 24 OCTOBER 2025 at 9.00 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press release: Q3: continued sales and earnings progress
News Preview
Q3: continued sales and earnings progress...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US98420X2027
X4 Pharmaceuticals Inc
XFOR
LISTED
NASDAQ
X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering
News Preview
BOSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR) (“X4” or the “Company”), a company driven to improve the lives of people with rare hematology diseases, today announced the pricing of its previously announced underwritten public offering of 45,860,000 shares of its common stock at a public offering price per share of $2...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: US37733W2044
GSK plc
GSK
LISTED
NYSE
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
News Preview
GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy, including a proteasome inhi...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
24.10.2025
ISIN: GB00BP2C3V08
Genflow Biosciences Plc
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Holding(s) in Company
News Preview
LONDON, UK / ACCESS Newswire / October 24, 2025 / TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW BIOSCIENCES PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obligationNameJonathan Mark SwannCity of...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US2197981051
QuidelOrtho Corp
QDEL
LISTED
NASDAQ
Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics
News Preview
SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 52 of its Science Bytes podcast, featuring George Wierschem, MBA, MT(ASCP), Senior Global Product Manager – Informatics....
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 23, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: CA53946V2066
Lobe Sciences Ltd.
LOBE
LISTED
CSE
Lobe Sciences Completes Debt Settlement to Improve Balance Sheet
News Preview
VANCOUVER, BC / ACCESS Newswire / October 23, 2025 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), operates as a pharmaceutical platform that develops novel therapies through a scalable model of shared services, global teams, and outsourced infrastructure. The Company creates intellectual prop...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
